Bernstein raises Northrop Grumman stock price target to $630 on improved outlook

Published 24/07/2025, 15:46
Bernstein raises Northrop Grumman stock price target to $630 on improved outlook

Investing.com - Bernstein raised its price target on Northrop Grumman (NYSE:NOC) to $630.00 from $586.00 on Thursday, while maintaining a Market Perform rating on the defense contractor’s stock. The new target represents potential upside from the current price of $575.47, with the stock already trading near its 52-week high and showing strong momentum with an 8.5% gain in the past week.

The price target increase follows Northrop Grumman’s second-quarter earnings report, which showed stronger-than-expected results with both earnings per share and revenues beating consensus estimates. The company reported $27.15 in diluted earnings per share over the last twelve months, with revenues reaching $40.5 billion.

Bernstein noted improved investor confidence after initial concerns that arose following first-quarter results, which had included a B-21 charge, Air Force delays in the Sentinel program, and declining Space revenues.

The research firm highlighted several positive developments, including additional funding for the B-21 and Sentinel programs, positive Sentinel EACs (Estimate At Completion), planned E-2D additions for the U.S., and overall improved operating performance across the company.

Bernstein has raised its earnings per share estimates for Northrop Grumman to $25.58 for 2025 (up from $25.21) and $27.65 for 2026 (up from $27.60), while noting that the possibility of a future B-21 charge remains and that recovery in the Space Systems segment is still anticipated. For deeper insights into Northrop Grumman’s financial health, valuation metrics, and 12+ additional exclusive ProTips, visit InvestingPro.

In other recent news, Northrop Grumman reported strong quarterly earnings, with earnings per share of $8.15, surpassing consensus estimates of $6.84 by 19%. This performance led RBC Capital to raise its price target for the company to $625, maintaining an Outperform rating. Truist Securities also increased its price target to $625, citing growth in the B-21 program and robust international demand. BofA Securities followed suit, raising its price target to $650 due to progress on the B-21 program and the belief that previous risks have been managed effectively. Additionally, Northrop Grumman secured a $495 million contract from the Department of Defense for engineering services, with work to be completed by 2030. The company was also awarded a $140 million contract modification to support the production of E-2D Advanced Hawkeye aircraft for Japan. These developments highlight Northrop Grumman’s continued momentum in securing significant defense contracts and achieving financial performance that exceeds market expectations.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.